H. Morrill, A. Caffrey, E. Noh, and K. Laplante, Epidemiology of Pneumococcal Disease in a National Cohort of Older Adults, Infectious Diseases and Therapy, vol.24, issue.2, pp.19-33
DOI : 10.1007/s40121-014-0025-y

K. Smith, M. Nowalk, R. M. Zimmerman, and R. , Cost-effectiveness of pneumococcal conjugate vaccination in immunocompromised adults, EPIBAC Données 2012 18, pp.3950-3956, 2013.
DOI : 10.1016/j.vaccine.2013.06.037

L. Fardet, I. Petersen, and I. Nazareth, Description of oral glucocorticoid prescriptions in general population. Rev Médecine Interne, pp.594-603, 2011.

S. Moberley, J. Holden, D. Tatham, and R. Andrews, Vaccines for preventing pneumococcal infection in adults, Cochrane Database Syst Rev, vol.1, p.422, 2013.

S. Aliberti, M. Mantero, M. Mirsaeidi, and F. Blasi, The role of vaccination in preventing pneumococcal disease in adults, Clinical Microbiology and Infection, vol.20, issue.5, pp.52-60, 2014.
DOI : 10.1111/1469-0691.12518

T. Staa, . Van, H. Leufkens, L. Abenhaim, B. Begaud et al., Use of oral corticosteroids in the United Kingdom, QJM. Feb, vol.193, issue.2, pp.105-116, 2000.

B. Gudbjornsson, U. Juliusson, and F. Gudjonsson, Prevalence of long term steroid treatment and the frequency of decision making to prevent steroid induced osteoporosis in daily clinical practice, Annals of the Rheumatic Diseases, vol.61, issue.1, pp.32-38, 2002.
DOI : 10.1136/ard.61.1.32

. Mdtext, I. Com, H. Remmelts, S. Meijvis, D. Biesma et al., Dexamethasone Downregulates the Systemic Cytokine Response in Patients with Community-Acquired Pneumonia. Clin Vaccine Immunol CVI Effect of corticosteroids on treatment failure among hospitalized patients with severe communityacquired pneumonia and high inflammatory response: a randomized clinical trial, JAMA Feb, vol.1219313, issue.177, pp.1532-1540, 2000.

L. Gensler and . Glucocorticoids, The Neurohospitalist, pp.92-99

Y. Blanloeil, L. Teurnier, Y. Demeure, D. Hougardy, D. Peterson et al., Corticoïdes en anesthésie-réanimation. emconsult. 1996. 16. Is enough attention being given to the adverse effects of corticosteroid therapy? Effets secondaires de la corticothérapie chez la personne âgée, 17. V. Peigne -Hôpital Européen Georges Pompidou, 2004.

K. Tolédano, C. Lebbe, and C. , Rev Médecine Interne Quand et comment arrêter une corticothérapie au long cours chez la personne âgée ? - Sheila Ardigo Systemic corticosteroid therapy: patients' adherence to dietary advice and relationship between food intake and corticosteroid-induced lipodystrophy Rev Médecine Interne, Mesures adjuvantes à une corticothérapie systémique prolongée : description des pratiques des médecins internistes français, pp.975-80, 2007.

A. Stuck, C. Minder, and F. Frey, Risk of Infectious Complications in Patients Taking Glucocorticosteroids, Clinical Infectious Diseases, vol.11, issue.6, pp.284-292, 1989.
DOI : 10.1093/clinids/11.6.954

C. Dejean and D. Richard, Mechanisms of action of glucocorticoids. Rev Médecine Interne, pp.264-272, 2013.

M. L. Catherine, ostéoporose chez les femmes ménopausées et chez les sujets traités par corticoïdes : méthodes diagnostiques et indications, 1925.

P. Deléage, M. Koenig, P. Cathébras, C. Levy, F. De-la-rocque et al., Corticothérapie orale prolongée et immunosuppresseurs en médecine générale. Médecine Impact of pneumococcal conjugate vaccine and of reduction of antibiotic use on nasopharyngeal carriage of nonsusceptible pneumococci in children with acute otitis media, Pediatr Infect Dis J, vol.225, issue.911, pp.419-441, 2006.

M. Kyaw, S. Clarke, G. Edwards, I. Jones, and H. Campbell, Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies, Epidemiology and Infection, vol.125, issue.3, pp.561-72, 2000.
DOI : 10.1017/S0950268800004787

F. Dorléans1, E. Varon2, A. Lepoutre1, S. G. Delelis-fanien, A. Séité et al., Impact de la vaccination par le vaccin antipneumococcique conjugué heptavalent sur l'incidence des infections invasives à pneumocoques en France. 31. Vaccinations -Guide pratique pour le médecin -Livret -09vod_guide-medecin.pdf http://www.inpes.sante.fr/50000 Couverture vaccinale antigrippale et antipneumococcique à partir de 65 ans : étude sur 299 patients ambulatoires. Rev Médecine Interne, 33. Verger P. Attitudes et pratiques des médecins généralistes de ville relatives à la vaccination en général et à celle, pp.656-60, 2009.

M. Kargar, M. Jahromi, F. Doosti, A. Handali, and S. , Molecular Investigation of Quinolone Resistance of Quinolone Resistance-Determining Region in Streptococcus pneumoniae Strains Isolated from Iran Using Polymerase Chain Reaction?Restriction Fragment Length Polymorphism Method. Osong Public Health Res Perspect, 2014.

R. Breiman, D. Keller, and M. Phelan, Evaluation of Effectiveness of the 23-Valent Pneumococcal Capsular Polysaccharide Vaccine for HIV-Infected Patients, Archives of Internal Medicine, vol.160, issue.17, pp.2633-2641, 2000.
DOI : 10.1001/archinte.160.17.2633

M. Fine, M. Smith, and C. Carson, Efficacy of Pneumococcal Vaccination in Adults, Archives of Internal Medicine, vol.154, issue.23, pp.2666-7748, 1994.
DOI : 10.1001/archinte.1994.00420230051007

E. Développement-et-Étude-d-mcglynn, S. Asch, J. Adams, J. Keesey, J. Hicks et al., impact d'un système informatique de tableaux de bord pour le suivi des pathologies chroniques en médecine générale. Prat Organ Soins The Quality of Health Care Delivered to Adults in the United States, N Engl J Med, 2003.